8-K: Chemours Reports Mixed Q1 2024 Results Amidst Market Headwinds

Chemours' first quarter 2024 results show a decline in net sales and income compared to the previous year, though some segments showed resilience and cost-cutting measures provided some offset.

Summary

• Chemours reported a 12% year-over-year decrease in net sales, reaching $1.4 billion in the first quarter of 2024.
• Net income attributable to Chemours was $52 million, or $0.34 per diluted share, a significant drop from $145 million, or $0.96 per diluted share, in the same quarter last year.
• Adjusted EBITDA was $193 million, down from $304 million in the prior-year quarter.
• The company experienced a 6% decrease in sales volumes and a 5% decline in prices, with a slight 1% headwind from portfolio impacts.
• Cash flows used in operations were $290 million, while capital expenditures totaled $102 million.
• The company returned $37 million to shareholders through dividends.
• The Advanced Performance Materials (APM) segment saw the largest decline in net sales, down 23%, while Titanium Technologies (TT) and Thermal & Specialized Solutions (TSS) experienced declines of 7% and 8%, respectively.
• Despite the overall decline, the company's TT segment saw flat Adjusted EBITDA year-over-year, with a 1 percentage point increase in Adjusted EBITDA margin to 12% due to cost reductions.
• TSS saw a strong adoption of Opteon products, but also experienced a decrease in Adjusted EBITDA by 18% due to price and volume declines and increased R&D investments.
• APM's Adjusted EBITDA decreased by 64% due to lower volumes and prices, as well as a maintenance outage in the previous quarter.
• Corporate expenses were $55 million, which was $25 million lower than anticipated due to the timing of costs related to the Audit Committee's Internal Review and lower stock-based compensation expenses.
• The company's net leverage ratio was approximately 3.7x on a trailing twelve-month Adjusted EBITDA basis.
• Total liquidity was $1.6 billion, including $746 million in unrestricted cash and cash equivalents and $853 million of revolving credit facility capacity.
• The company expects a working capital source of cash in the second half of the year as it sells product from inventory and collects receivables from customers.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant declines in key financial metrics, particularly in net income and Adjusted EBITDA, and a notable weakness in the APM segment. While there are some positives, such as cost reductions in TT and strong Opteon adoption in TSS, the overall tone is negative due to the substantial year-over-year declines and increased cash usage.

Positives

• The Titanium Technologies (TT) segment showed resilience with flat Adjusted EBITDA year-over-year and an increased margin due to cost reductions.
• The Thermal & Specialized Solutions (TSS) segment saw strong adoption of Opteon products.
• Corporate expenses were lower than anticipated, providing a positive offset to Adjusted EBITDA.
• The company expects a working capital source of cash in the second half of the year.
• The company returned $37 million to shareholders through dividends.

Negatives

• Net sales decreased by 12% year-over-year, primarily due to declines in volume and price.
• Net income attributable to Chemours decreased significantly to $52 million, or $0.34 per diluted share.
• Adjusted EBITDA decreased by 37% year-over-year.
• The Advanced Performance Materials (APM) segment experienced a substantial 23% decline in net sales and a 64% decrease in Adjusted EBITDA.
• Cash flows used in operations were $290 million, an increase of $166 million from the prior year.
• The company experienced a 6% decrease in sales volumes and a 5% decline in prices.

Risks

• The company faces continued weakness in the Advanced Performance Materials (APM) segment.
• The company is experiencing softer demand in some end markets, particularly in the Foam, Propellants and Other products portfolio and in the automotive original equipment manufacturer (OEM) market.
• The company is exposed to currency fluctuations, which represented a 3%, or $8 million, headwind compared to the prior-year quarter.
• The company is experiencing increased R&D investments in immersion cooling and next generation refrigerants, which may impact short-term profitability.
• The company expects Operating Cash Flow to reflect a total usage of approximately $500 million in the second quarter of 2024, including an expected outflow of $606 million related to the Water District Settlement Fund.

Future Outlook

The company expects sequential growth in net sales and Adjusted EBITDA in the second quarter of 2024 across all segments, with TT expected to grow by approximately 15%, TSS by mid-teens, and APM by low-teens. Corporate expenses are expected to increase sequentially by $15 million to $20 million. Operating cash flow is expected to reflect a total usage of approximately $500 million in the second quarter of 2024.

Management Comments

• Chemours CEO Denise Dignam stated that first quarter net sales were in line with expectations across all three segments.
• She also noted that consolidated Adjusted EBITDA was higher than anticipated due to the allocation of TiO2 volumes to higher-yield regions, the timing of lower-cost ore consumption, the strong execution of the TT Transformation Plan, and lower-than-expected corporate costs.
• Management highlighted the strong adoption of Opteon products in TSS and a modest recovery in the APM orderbook since year end.
• The company remains focused on ramping capacity in its Performance Solutions product portfolio to serve growing opportunities, primarily in the semiconductor manufacturing market.
• Management also emphasized the delivery of significant efficiencies and cost reductions through the TT Transformation Plan.

Industry Context

The results reflect a mixed performance in the chemical industry, with some segments showing resilience while others face headwinds from market conditions and demand fluctuations. The strong adoption of Opteon products in TSS aligns with the industry trend towards more environmentally friendly solutions. The challenges in APM highlight the impact of economic sensitivity on certain specialty materials markets. The company's focus on cost reduction and efficiency improvements is a common theme in the industry as companies seek to navigate market volatility.

Comparison to Industry Standards

• Compared to peers like Dow and DuPont, Chemours' Q1 2024 results show a similar trend of mixed performance across different segments, with some areas experiencing growth while others face challenges.
• Dow, for example, has also reported facing headwinds in certain segments due to lower demand and pricing pressures, similar to Chemours' APM segment.
• DuPont, while having a different business model, has also emphasized cost-cutting measures and efficiency improvements, which aligns with Chemours' TT Transformation Plan.
• In terms of specific product lines, the adoption of Opteon in TSS is comparable to other companies' efforts to transition to more sustainable refrigerant solutions, such as Honeywell's Solstice line.
• The decline in APM's performance is similar to what other specialty materials companies have experienced due to economic slowdowns in certain end markets, such as automotive and electronics.
• Chemours' net leverage ratio of 3.7x is within the range of other chemical companies, but the company's cash flow usage in Q1 is a concern compared to peers with stronger cash generation.

Stakeholder Impact

• Shareholders will be impacted by the decrease in net income and Adjusted EBITDA, as well as the increased cash usage.
• Employees may be affected by the company's cost reduction efforts and restructuring programs.
• Customers may experience changes in product availability and pricing due to market dynamics and the company's strategic shifts.
• Suppliers may be impacted by changes in the company's procurement strategies and production volumes.
• Creditors may be concerned about the company's increased debt and cash flow usage.

Next Steps

• The company expects sequential growth in net sales and Adjusted EBITDA in the second quarter of 2024.
• The company will hold a conference call and webcast on May 1, 2024, to discuss the first quarter 2024 financial results.
• The company anticipates that expenses related to the remediation of material weaknesses in internal controls over financial reporting and other recommendations arising from the Audit Committees Internal Review will be relatively flat quarter-over-quarter.

Key Dates

Keywords

Chemours, financial results, net sales, adjusted EBITDA, net income, Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, Opteon, cost reduction, liquidity, dividends